Synthesis, SAR and Biological Evaluation of Natural and Non-natural Hydroxylated and Prenylated Xanthones as Antitumor Agents

Author(s): Xiaojin Zhang, Xiang Li, Suofu Ye, Yu Zhang, Lei Tao, Yuan Gao, Dandan Gong, Meiyang Xi, Huyan Meng, Mingqian Zhang, Wenlei Gao, Xiaoli Xu, Qinglong Guo, Qidong You

Journal Name: Medicinal Chemistry

Volume 8 , Issue 6 , 2012

Become EABM
Become Reviewer
Call for Editor


In order to explore the detailed structure-activity relationship (SAR) around xanthone scaffold bearing hydroxyl and prenyl moieties, twenty-nine natural and non-natural hydroxylated and prenylated xanthones have been synthesized and evaluated for their in vitro anti-proliferative activities against five human cancer cell lines, including HepG2 (hepatocelluar carcinoma), HCT-116 (colon carcinoma), A549 (lung carcinoma), BGC823 (gastric carcinoma) and MDAMB- 231 (breast carcinoma). The SAR analysis revealed that the anti-proliferative activity of the xanthones is substantially influenced by the position and number of attached hydroxyl and prenyl groups, and the presence of hydroxyl group ortho to the carbonyl function of xanthone scaffold contributes significantly to their cytotoxicity. The new prenylated xanthone 20 with a relatively simple structure, namely 1,3,8-trihydroxy-2-prenylxanthone, was found to exhibit potent antitumor activities comparable to α-mangostin against all the five cancer cell lines. Further mechanistic studies suggested that compound 20 induces apoptosis and causes cell cycle arrest at S phase in HepG2 cells. These results have highlighted compound 20 as a new potential lead candidate for future development of novel potent broad-spectrum antitumor agents.

Keywords: Antitumor, Anti-Proliferative, Apoptosis, Cell Cycle Arrest, SAR, α-Mangostin, Xanthone

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 25 September, 2012
Page: [1012 - 1025]
Pages: 14
DOI: 10.2174/1573406411208061012
Price: $65

Article Metrics

PDF: 51